202 filings
Page 6 of 11
8-K
jb7dcu071r0 lj7nje
4 Mar 21
Evofem Biosciences Reports Fourth Quarter and Year-End 2020
4:00pm
8-K
nyhmuu nnejpte5
22 Feb 21
Regulation FD Disclosure
6:12am
8-K
h5a6pivjpon3c681z
5 Feb 21
Regulation FD Disclosure
8:02am
8-K
0w8jv80ztd19asauul
1 Dec 20
Regulation FD Disclosure
4:05pm
8-K
vbi46 s932
18 Nov 20
Regulation FD Disclosure
5:04pm
8-K
wzb7rrjftxwq
9 Nov 20
Evofem Biosciences Reports Third Quarter 2020
4:04pm
8-K
ohefn6z0b5bk s6
15 Oct 20
Evofem Biosciences Secures $25 Million
8:05am
8-K
brlmi3x4rpc5uxygd
14 Sep 20
Regulation FD Disclosure
3:21pm
8-K
0boqc92rw kn
4 Aug 20
Evofem Biosciences Reports Second Quarter 2020
8:01am
8-K
y42fskzy
18 Jun 20
Submission of Matters to a Vote of Security Holders
4:24pm
8-K
emz vk8wggrcyfuz8e
9 Jun 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:09pm
8-K
v1syyehbz6soaq2a9
3 Jun 20
Other Events
4:52pm
8-K
f0091rkyh
2 Jun 20
Termination of a Material Definitive Agreement
4:21pm
8-K
rnqk8j e6c8
22 May 20
Other Events
4:05pm
8-K
j0k4ol0yle
12 May 20
Departure of Directors or Certain Officers
4:11pm
8-K
e7trzh7s6xm
6 May 20
Evofem Biosciences Reports First Quarter 2020 Financial Results
8:01am
8-K
1yq1hvmlq k2
28 Apr 20
Evofem Biosciences to Report First Quarter 2020 Results and Update on Financing and Commercial Launch Plans
7:59am
8-K
x00syk 2oe
27 Apr 20
Evofem Biosciences Secures up to $25 Million in Convertible Note Financing
8:00am
8-K
bn6b5 mwrr
17 Apr 20
Entry into a Material Definitive Agreement
4:17pm
8-K
c228zu37 pu5f70zp
25 Mar 20
Evofem Biosciences Adopts Shareholder Rights Agreement
5:00pm